You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BAY59-7939

Showing 1 - 25 of 947
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Xarelto for Venous Thromboembolism (VTE)

Completed
  • Venous Thromboembolism
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Multiple Locations, Japan
    Many locations
Oct 30, 2022

Learn About Venous Thromboembolism Treatment With Rivaroxaban in

Completed
  • Treatment of Venous Thromboembolism
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Japan Databases, Japan
  • +1 more
Jan 10, 2023

Atrial Fibrillation and Heart Failure Who Are ReceivingDirect

Completed
  • Heart Failure
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Multiple Locations, Spain
    Many Locations
Dec 29, 2022

Gain Information on Drug Xarelto for Prevention of Brain Attack

Completed
  • Non-valvular Atrial Fibrillation (NVAF)
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Multiple Locations, Taiwan
    Many Locations
Jan 29, 2023

Gather Information About Rivaroxaban in United Kingdom Who Have

Completed
  • Treatment of Venous Thromboembolism in Cancer Patients
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +2 more
  • Multiple Locations, United Kingdom
    Many locations
Sep 19, 2022

Safety of Rivaroxaban in Children Under 2 Years Old With Venous

Not yet recruiting
  • Venous Thromboembolism
  • Children Under 2 Years
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Standard of care (SOC)
  • Multiple Locations, Denmark
  • +3 more
Jun 9, 2023

Gather Information About Rivaroxaban in Sweden With Cancer Who

Active, not recruiting
  • Treatment of Venous Thromboembolism in Cancer Patients
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +3 more
  • Multiple Locations, Many Locations, Sweden
    Swedish registries
Aug 18, 2022

Cancer Associated Thrombosis for Rivaroxaban - United States

Completed
  • Treatment of Venous Thromboembolism in Cancer Patients
  • Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +2 more
  • Multiple Locations, Connecticut
    Many Locations
May 18, 2022

Xarelto for Real Life Anticoagulation in Pulmonary Embolism in

Completed
  • Pulmonary Embolism
  • Rivaroxaban(Xarelto, BAY 59-7939)
  • Multiple Locations, China
    Many locations
Jan 3, 2022

Kidney's Ability to Work Properly in Korean Non-valvular Atrial

Active, not recruiting
  • Non-valvular Atrial Fibrillation (NVAF)
  • Multiple Locations, Korea, Republic of
    Many locations
Aug 11, 2022

Rivaroxaban Versus Low-molecular-weight Heparin and

Completed
  • Venous Thromboembolism
  • Rivaroxaban (Xarelto, BAY 59-7939)
  • LMWH and Phenprocoumon
  • Multiple Locations, Germany
    Multiple facilities
Apr 27, 2022

Effectiveness of Rivaroxaban When Given Together With

Recruiting
  • Prevention of Atherothrombotic Events
  • +2 more
  • Rivaroxaban (Xarelto,Bay 59-7939)
  • Acetylsalicylic acid(ASA)
  • Multiple Locations, India
    Many locations
Aug 22, 2022

Gather Information How Often Venous Thromboembolism Occurs in

Completed
  • Venous Thromboembolism (VTE)
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +2 more
  • Multiple Locations, Sweden
    Many Locations
Nov 24, 2021

Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban

Active, not recruiting
  • Treatment of Venous Thromboembolism in Cancer Patients
  • +2 more
  • Wuppertal, Germany
    Bayer
Jul 25, 2022

Patient and Physician Knowledge of Key Safety Messages

Completed
  • Anticoagulation
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Multiple Locations, France
  • +3 more
Apr 5, 2021

Stroke and Non-Central Nervous Systemic Embolism in Renally

Completed
  • Non-valvular Atrial Fibrillation (NVAF)
  • Rivaroxaban(Xarelto,BAY 59-7939)
  • Multiple Locations, Korea, Republic of
    Many locations
Dec 21, 2021

Potential Adverse Outcomes in Routine Clinical Practice

Completed
  • Venous Thrombosis
  • +3 more
  • Rivaroxaban (Xarelto, Bay59-7939)
  • Standard of care
  • Multiple Locations, Germany
    (unnamed)
Oct 21, 2021

Potential Adverse Outcomes in Routine Clinical Pratice

Completed
  • Venous Thrombosis
  • +3 more
  • Rivaroxoban (Xarelto, Bay59-7939)
  • Standard of care
  • Multiple Locations, Netherlands
    (unnamed)
Sep 22, 2021

Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Completed
  • Acute Coronary Syndrome
  • +3 more
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Standard of care drugs
  • Multiple Locations, Sweden
    Many Locations
Sep 22, 2021

Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Completed
  • Venous Thrombosis
  • +3 more
  • Rivaroxaban (Xarelto, Bay59-7939)
  • +2 more
  • Multiple Locations, United Kingdom
    (unnamed)
Sep 22, 2021

Major Cardiovascular Events in Nonvalvular Atrial Fibrillation

Completed
  • Atrial Fibrillation
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Multiple Locations, Spain
    (unnamed)
Jul 15, 2021

Thromboembolic Disorders Trial in Mönchengladbach (Rivaroxaban (Xarelto, BAY59-7939))

Completed
  • Thromboembolic Disorders
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Mönchengladbach, Nordrhein-Westfalen, Germany
    CRS Clinical-Research-Services Mönchengladbach GmbH
Jan 20, 2021

Learn More About Benefits and Side-effects of Drugs Rivaroxaban

Completed
  • Atrial Fibrillation
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +2 more
  • Many Sites, United Kingdom
    Many facilities
Oct 27, 2021

Xarelto [SPAF] Post-marketing Surveillance in Japan

Completed
  • Brain Ischemia
  • Rivaroxaban(Xarelto, BAY59-7939)
  • Multiple Locations, Japan
    (unnamed)
Dec 29, 2020

Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral

Completed
  • Atrial Fibrillation
  • Multiple Locations, Germany
    Many Locations
Nov 24, 2020